Posted on March 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
Posted on March 22, 20243/22/24
Pioneering the Path: How Medical Affairs is Charting the Course for Pre- and Post-Launch Strategies
Posted on March 14, 20243/14/24
Establishing the Pricing and Value Proposition of AI/MedTech Solutions in Healthcare
Posted on March 11, 20243/11/24
Navigating the Frontier: Generative AI Revolutionizing Healthcare and Life Sciences
Posted on February 19, 20242/19/24
Navigating Successful Partnerships in the Pharmaceutical Industry: Insights from Shorla Oncology CEO Sharon Cunningham
Posted on February 14, 20242/14/24
Excel in Market Access Success: Key Considerations for Leveraging Your Evidence
Posted on January 23, 20241/23/24
CES 2024 Recap – How the Future of Healthcare Will Continue to Be Driven By Innovation & AI
Posted on January 22, 20241/22/24
EVERSANA’s High-Quality HEOR Methods Recognized in Published Independent Review
Posted on January 15, 20241/15/24